22 results
P
general populations, sexually transmitted infection clinic attendees, symptomatic populations, human immunodeficiency virus (HIV)-positive individuals, individuals in HIV-discordant couples, men who have sex with men
I/C
seroprevalence among different populations
O
pooled mean seroprevalence, proportion of HSV-2 isolation in laboratory-confirmed genital herpes, proportion of HSV-2 isolation in genital ulcer disease
P
healthy children, healthy adults
I/C
herpes simplex virus type 1 (HSV-1), laboratory-confirmed genital herpes
O
seroprevalence, proportion of HSV-1 detection
P
South Africa, India, Turkey, Pakistan, Canada, Hong Kong, China
I/C
α-HCH, β-HCH, γ-HCH, ∑-HCH, Heptachlor, Aldrin, p,p'-DDE, p,p'-DDT, ∑-DDT, ∑-OCP, Surface water, Drinking water, Seawater, Groundwater
O
Concentration and prevalence of POPs, Carcinogenic risk, Non-carcinogenic risk
P
patients with COVID-19
I/C
diabetes, no diabetes
O
mortality
P
Indigenous adolescents
I/C
primary health care services, non-Indigenous adolescents
O
access to health care
P
RA patients using bDMARDs
I/C
concomitant use of csCMARD, non-csDMARD exposure
O
discontinuation of bDMARD therapy, switching of bDMARDs, percent change in dose of bDMARD compared to initial dose
P
people with non-exudative age-related macular degeneration (AMD)
I/C
photobiomodulation (PBM) therapy, standard care, sham treatment, or no treatment
O
best-corrected visual acuity (BCVA); contrast sensitivity; near vision; low luminance density score; reading speed; vision-related quality of life score; and adverse events such as progression of AMD and conversion to exudative AMD
P
adult participants
I/C
food insecurity interventions, interventions that described addressing participants' food needs or reporting food insecurity as an outcome
O
food insecurity status, health outcomes, and health care utilization
P
children
I/C
quadrivalent live attenuated influenza vaccine (LAIV4), inactivated influenza vaccine (IIV)
O
effectiveness against influenza
P
COVID-19 patients
I/C
observational studies, inside and outside of China
O
epidemiological variations, symptoms, fatality rate